Antiparasitic and Covid
With the ongoing pandemic of the Coronavirus, the scientific world is working hard to find a solution to this deadly virus. Although multiple vaccines are now available in the market, many researchers are now turning towards antiparasitic drugs as a potential treatment for Covid-19. Antiparasitic drugs are commonly used to treat diseases caused by parasitic infections. However, some recent studies have shown that these drugs could also be effective against the Coronavirus. Ivermectin, which is primarily used to treat roundworms, has been found to be effective against the Covid-19 virus. Some studies have shown that it can reduce the viral load in the system, leading to a faster recovery of the patients. Hydroxychloroquine, which is commonly used for malaria, is also being researched as a possible Covid-19 treatment. Even though some initial trials did not show any significant results, further studies are underway to assess the efficacy of the drug in treating coronavirus patients. Another drug, Niclosamide, which is used to treat tapeworm infection, is now being researched as a potential treatment for Covid-19. It has been shown to block the entry of the virus into the host cells, which can prevent the spread of the virus in the body. In conclusion, antiparasitic drugs could prove to be a game-changer in the fight against Covid-19. Although more research is required to establish their efficacy, it is an encouraging sign that scientists are exploring all possible avenues to combat the virus.
←